AGC Biologics社、二重特異性抗体のプロセス開発・受託製造プロジェクトを開始

AGC Inc. published this content on May 26, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 26, 2026 at 02:35 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]